Elucidating the precise pharmacological mechanism of motion (MOA) of Normally developing compounds may be demanding. Even though Tarselli et al. (60) developed the 1st de novo artificial pathway to conolidine and showcased that this The natural way transpiring compound efficiently suppresses responses to the two chemically induced and inflammation-